# Corvus Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Jan 27, 2026

- Company: [Corvus Pharmaceuticals, Inc.](/companies/crvs.md) (CIK 1626971)
- Form: SCHEDULE 13D/A
- Filed: 2026-01-27
- Accepted by EDGAR: Jan 27, 2026, 20:38 ET
- Period: not reported
- Accession: 0000947871-26-000068
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1626971/000094787126000068/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626971/000094787126000068/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1626971/000094787126000068/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 27, 2026.
Source: SEC EDGAR, the filing index for accession 0000947871-26-000068. Last ingested by Listed: Nov 15, 2026, 00:49 ET. No prices; not investment advice.
